Financial News · Live Terminal

Page 156 of 324

Research Alert: CFRA Maintains Buy Opinion On Shares Of Coherent Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our target by $55 to $412, 41x our CY 27 EPS estimate of $10.06, above COHR's three-year average of approximately 20x as significant AI demand has improved growth and visibility well beyond historical levels. We lower our FY 26 (Jun.) EPS by $0.13 to $5.48, increase FY 27's by $0.74 to $8.32, and lift FY 28's by $2.31 to $11.91. COHR is, impressively, a full quarter ahead of schedule in hitting its initial goal of doubling indium phosphide (InP) production capacity in CY 26. The company is also ambitiously projecting another doubling of InP capacity in CY 27, which - as the main supply constraint for COHR's advanced AI products - offers significant upside to sales growth and margin expansion, in our view. We also like that COHR has inked additional long-term agreements for CPO-related products with major data center/systems customers following the NVDA agreement announced in March, which should continue to improve visibility and lead to smoother growth results, with orders now extending through CY 28.

$COHR

Research54d ago

Research Alert: CFRA Maintains Hold Rating On Shares Of Akamai Technologies Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our Hold recommendation on shares of AKAM, but increase our target price to $159, from $121, on a forward P/E of 22x our 2027 EPS projection of $7.21. We adjust our 2026 EPS forecast to $6.92 from $6.91, but trim our 2027 EPS projection to $7.21 from $7.63. AKAM reported Q1 2026 revenue of $1.074B, up 6% Y/Y (4% constant currency), with Cloud Infrastructure Services delivering exceptional 40% Y/Y growth to $95M, accelerating from 39% in Q4 2025. Security revenue grew 11% Y/Y to $590M, while Delivery declined 7%. AKAM announced a notable $1.8B CIS deal with a leading U.S.-based frontier model provider over seven years, which we view as a significant win amid competition, and we also see the potential for more pipeline conversions ahead. However, the trade off is lower margins and a significant ramp in capex expectations for the full-year, now 40% to 42% of sales. While we like the growth opportunity, we think current valuation is less attractive and look for a better entry point.

$AKAM

Research54d ago

Research Alert: CFRA Maintains Buy Opinion On Shares Of Huntington Ingalls Industries

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target price by $53 to $395, led by multiple contraction due to margin concerns. Following the disappointing Q1 earnings, we lower our assumed P/E multiple from 21.0x to 18.5x, applied to our unchanged 2027 EPS estimate of $21.33. During the last three years, HII has traded at an avg. fwd P/E of 16.5x and defense peers are trading at an avg. fwd P/E of 26.0x. Although we reiterate our bullish long-term outlook, we acknowledge concerns about margin compression, and we decrease our 2026 EPS estimate from $17.86 to $17.40. HII reaffirmed its full-year guidance, including shipbuilding revenue of $9.7B-$9.9B with margins of 5.5%-6.5%, and free cash flow of $500M-$600M. The company maintains a robust $54B backlog and expects medium-term revenue growth of ~6% annually in shipbuilding. While near-term margin pressure persists from pre-COVID contracts, we view the long-term outlook as favorable given strong defense spending tailwinds and improving execution on post-COVID ships beginning in 2027.

$HII

Research54d ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of Public Service Enterprise Group Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $4 to $86, valuing shares at 19.6x our next-12-month EPS estimate of $4.41 - a slight premium to its three-year average of 19.4x and largely in line with peers. We trim our 2026 EPS view by $0.05 to $4.37 and 2027 by $0.03 to $4.70. Our Hold opinion reflects our view that valuation fairly reflects the company's improved growth trajectory and nuclear positioning in capacity-constrained PJM, leaving little upside potential at current levels. PSEG Nuclear's 3,758 MW fleet delivered 8.0 TWh in Q1 2026 at a 95.5% capacity factor, with management forecasting 30-32 TWh for full-year 2026. Large-load service inquiries remained at ~11 GW as of Q1 2026, leveling off after significant growth through 2025. Management expects 10-15% conversion rates based on historical precedent. We expect EPS and dividends to grow at CAGRs (2025 to 2028) of 7.5% and 5.4%, respectively, slightly below Multi-Utility peer medians of 7.6% and 6.0%, respectively. Shares yield 3.4% versus the 3.2% peer median.

$PEG

Research54d ago

Research Alert: CFRA Maintains Buy Opinion On Shares Of Semtech Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price to $140 from $100, on a higher revised P/E of about 48x our CY 2027 EPS of $2.90, which is above wireless peers and the range of analog peers to reflect our view of upside to consensus views and superior growth prospects over the next three years. We believe that SMTC is well positioned to capitalize on the AI infrastructure build-out, with data center revenue growing 58% in FY 26 and guided for over 50% in FY 27. The recent acquisition of HieFo Corporation, a manufacturer of Indium Phosphide lasers, is a pivotal move to vertically integrate and increase content in next-generation 1.6T and 3.2T optical modules, expanding the content opportunity from ~$8 in 800G modules to ~$80 in 3.2T modules. We are confident in SMTC's technology roadmap, highlighting imminent product ramps in Active Copper Cables and 1.6T optical solutions, which could drive $100M+ incremental revenue opportunity as hyperscalers transition to higher-speed architectures over the next two to three years.

$SMTC

Research54d ago

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Celsius Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $15 to $55, based on a 2027 P/E of 24.4x, a justified discount to CELH's historic average multiples. We increase our adjusted EPS estimates by $0.10 to $1.85 for '26 and by $0.15 to $2.25 for '27. Following CELH's Q1 earnings beat, we are raising our estimates and reiterating a Buy on the shares. CELH's net sales rose 138% to $782.6M ($22.0M above consensus), but gross margin contracted 400 bps to 48.3% (40 bps below consensus) on acquisition mix and integration costs. While we weren't thrilled by CELH's 2025 acquisition of Rockstar Energy and how the growth of its legacy CELSIUS brand has slowed dramatically (brand revenue up only 6% in Q1), the Alani Nu acquisition was a transformational deal that continues to pay off and drive growth. Beverage companies are facing significant fundamental headwinds, but CELH stands out from a growth perspective, and we think investors can expect continued debt reduction and share repurchases going forward, which should help boost EPS.

$CELH

Research54d ago

Research Alert: CFRA Maintains Hold Rating On Shares Of Great-west Lifeco Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 3-STARS (Hold) rating on GWO and increase our target price to CAD81 from CAD70. The quarter saw strong execution across all business lines, only to be tempered by our concerns over a red hot equity market and valuation. Base earnings of CAD1,239M was up 20% Y/Y and base EPS of CAD1.37 was up 23%. ROE reached +19% for the first time as Empower operating margins ran to 33.5% (+320 basis points) and 39% (+850 basis points) in Retirement and Wealth. The strong quarter saw share buybacks continuing with CAD578M used for repurchases in Q1. Valuation, however, is stretched. On both a historical and absolute basis, the forward earnings multiple is exceeding the long-term upper bands as equity markets run red hot into a continuing energy crisis. We believe the downside risk is elevated as AUM growth, fee income, and the Empower margins are correlated with equity market performance. We raised our 2026 EPS estimate to CAD5.47 from CAD5.39 and 2027's to CAD6.01 from CAD5.82.

$GWO

Research54d ago

Research Alert: CFRA Keeps Buy Rating On Shares Of Global Payments Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Following Q1 results, we lower our 12-month target price by $7 to $85, 5.2x our 2027 EPS view vs. GPN's three-year historical forward P/E average of 8.7x and the peer average of 6.5x. We keep our 2026 EPS estimate at $13.85 and decrease 2027's to $16.20 from $16.45. Management reaffirmed its 2026 outlook, projecting approximately 5% adjusted revenue growth, significant margin expansion, and EPS growth of 13% to 15%. This confidence is underpinned by the successful, ahead-of-schedule integration of Worldpay, which is already yielding tangible cross-sell victories, such as a major software deal with existing client Subway. Simultaneously, the company's core software platform, Genius, demonstrated accelerating momentum with bookings nearly doubling Y/Y and new client yields increasing by over 30%. Underscoring this positive outlook, GPN is aggressively returning capital to shareholders, announcing a new $500 million accelerated share repurchase program after returning over $600 million in the first quarter alone.

$GPN

Research54d ago

Research Alert: CFRA Keeps Hold Opinion On Shares Of Realty Income Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our price target by $3 to $67, implying 15.2x our 2026 FFO estimate, a premium to O's three-year average multiple of 13.6x as the outlook for lower borrowing costs and improving yields in the U.K. is likely to support higher FFO growth. We decrease our 2026 FFO estimate by $0.02 to $4.42 and increase 2027 by $0.04 to $4.59. O continued to invest heavily in Europe and the U.K. in Q1, totaling $1.0B of the $2.8B in total investments, while remaining disciplined as management closed on just 9% of the $31B in opportunities it sourced. O has also moved into the private market with strategic partnerships, a $1B JV fund with Apollo, and its $1.7B capital raise for its Perpetual Life U.S. Core+ fund. We believe this increases its TAM and opens the door for larger private fund opportunities. Despite the increased acquisition pace, we note net debt-to-EBITDA at 5.2x leaves room for further large-scale activity this year while total debt carries only a 4.34% blended rate.

Research54d ago

Research Alert: CFRA Reiterates Buy Rating On Nyse Shares Of Brookfield Asset Management Ltd.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target price at $60 applying a forward P/E of 31.5x compared to the three-year historical average at 30.2x. Our valuation is supported by our view on growth of the business, diversification in high quality markets, and the durability of earnings. We raise our 2026 distributed earnings per share by $0.10 to $1.90 and increase 2027 by $0.10 to $2.25, both near consensus estimates. Compared to ALT peers that trade in the 20x-30x range, our premium valuation for BAM is based on its global leadership with diversified investments and performance track record. The firm has been handling infrastructure investing for decades and stands to benefit from AI-related investments in power, transmission, and data centers. Electricity and power are a key areas for AI infrastructure. We think BAM is best positioned for this opportunity. The market environment across all business segments remains strong, in our view. We see healthy fundraising and monetization, and the dividend yield is 3.25%.

$BAM

Research54d ago

Research Alert: CFRA Reiterates Buy Opinion On Tsx Shares Of Brookfield Asset Management Ltd.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target at CAD82 applying a forward P/E of 31.5x compared to the three-year historical average at 30.2x. Our valuation is supported by our view on growth of the business, diversification in high quality markets, and the durability of earnings. We raise our 2026 distributed earnings per share by $0.10 to $1.90 and increase 2027 by $0.10 to $2.25, both near consensus estimates. Compared to ALT peers that trade in the 20x-30x range, our premium valuation for BAM is based on its global leadership with diversified investments and performance track record. The firm has been handling infrastructure investing for decades and stands to benefit from AI-related investments in power, transmission, and data centers. Electricity and power are a key areas for AI infrastructure. We think BAM is best positioned for this opportunity. The market environment across all business segments remains strong, in our view. We see healthy fundraising and monetization, and the TSX shares' dividend yield is 4.11%.

$BAM

Research54d ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of The Goodyear Tire & Rubber Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We cut our 12-month target by $3 to $7, based on a 2027 P/E of 10.0x, a steep but justified discount to Goodyear's 10-year mean forward P/E of 13.5x. We lower our adjusted EPS estimates to $0.25 from $1.00 for '26 and to $0.70 from $1.40 for '27. Goodyear posted Q1 adjusted EPS of -$0.39 vs. -$0.04, ahead of the -$0.43 consensus. The beat was due to stronger-than-expected sales, as revenue fell 8.7% to $3.88B ($70M ahead of consensus) on an 11.6% drop in tire sales volume, partially offset by higher prices. The segment operating margin contracted 220 bps to 2.4%. Looking ahead, management said it expects increased pressure on tire industry demand and higher raw material costs stemming from Middle East conflict. Goodyear continues to face demand-related issues and the recent spike in crude oil prices should equate to meaningful pressures on profitability, as approximately two-thirds of Goodyear's raw materials costs are petroleum-based (and it doesn't hedge commodity prices). We remain at a Hold on the shares.

$GT

Research54d ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of Valvoline Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month target of $38, based on a P/E of 17.3x our FY 27 (Sep.) EPS estimate, a justified discount to the stock's 10-year average forward P/E of 19.2x. Following VVV's earnings release, we are maintaining our estimates and our Hold opinion on the shares. Our adjusted EPS estimates remain $1.80 for FY 26 and $2.20 for FY 27. VVV posted Q2 FY 26 (Mar.) adjusted EPS of $0.41 vs. $0.34 (+21%), well ahead of the $0.34 consensus. Revenue rose 25% to $504M ($9M above consensus), and adjusted EBITDA margin expanded 60 bps to 26.5% (160 bps ahead of consensus). VVV's top-line growth should accelerate to 21% in FY 26 (vs. 6% in FY 25), driven by 162 net new stores added through its acquisition of Breeze AutoCare on December 1, 2025 (for $593M) plus SSS growth of approximately 6%. SSS growth is benefiting from a record-high average U.S. vehicle fleet, which is increasing maintenance frequency. Still, we view the stock's valuation as fair, preferring other names in the auto retail space.

$VVV

Research54d ago

Research Alert: CFRA Maintains Hold Rating On Shares Of Medline Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month price target of $46 (lowered from $52) is 27.7x our 2027 EPS estimate, a small discount to the 28.4x forward average since the recent IPO. Our 2026 EPS estimate is $1.50 (up from $1.47), while our 2027 EPS estimate is $1.60 (down from $1.65). We look favorably on MDLN raising 2026 sales growth expectations despite looming headwinds facing the industry, supported by customer growth, including a new Prime Vendor signing with Mohwak Medbuy Corporation (serving nine acute care hospitals) in Canada. Looking ahead, MDLN sees reimbursement cuts and insurance coverage losses, stemming from recent policy developments such as the expiration of ACA enhanced premium tax credits and the passage of the One Big Beautiful Bill Act, which may cause moderation in healthcare utilization during 2H 2026. We also anticipate margin pressure from inflationary fuel, plastics, and other material costs. We maintain our Hold rating.

$MDLN

Research54d ago

Research Alert: CFRA Maintains Hold Opinion On Shares Of The Clorox Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price is $112 (down from $121 on May 7), 20x our FY 26 view of $5.60. Our multiple is a discount to the 22.2x three-year average forward P/E, reflecting CLX's recent dynamic performance such as disruptions and portfolio restructuring amid a softening demand environment. We lower our FY 26 EPS estimate by $0.30 to $5.60 and FY 27 by $0.52 to $6.25. CLX reported Q3 fiscal 2026 results that reflected a mixed operating environment, with net sales of $1.67B (in line with estimates) flat vs. the prior year. EPS grew 13% to $1.64 from $1.45, $0.10 above consensus. Household and International segments delivered solid growth of 3% and 8%, respectively, while the Lifestyle segment contracted 9% on lower consumption and retail inventory adjustments. Health and Wellness sales held steady with volume gains being offset by unfavorable price/mix dynamics. Gross margin compressed 140 bps to 43.2% from 44.6% in the prior year due to elevated manufacturing and logistics costs.

$CLX

Research54d ago

Research Alert: Tou Maintained Buy As Lower Gas Pricing Dents Cash Flow: Tp Cad74

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our Buy (4-STARS) rating and decrease our target price to CAD74. This is based on an EV/EBITDA multiple of 6.8x our 2027 EBITDA projection. We reduced the EBITDA multiple from 7.2x to 6.8x to bring it closer in line with the long-term bands. While still a premium multiple, we believe the Iranian war, ARC deal, and global energy sentiment will elevate multiples for a time. Q1 production was 666,089 boe/d, within guidance. Cash flow declined 10% to CAD862.2M, reflecting lower gas pricing realizations, which were down 17% Y/Y. Overall, guidance was maintained and infrastructure projects remain on schedule. No special dividend or base dividend increase was announced.

$TOU

Research54d ago

BofA Securities Downgrades Planet Fitness to Neutral From Buy, Price Target is $59

Planet Fitness (PLNT) has an average rating of overweight and mean price target of $78.39, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $45.52, Change: $+1.51, Percent Change: +3.43%

$PLNT

Research54d ago

Research Alert: CFRA Raises Rating On Itt Shares To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target following Q1 results to $250 from $220, valuing shares at 27x our 2027 EPS outlook of $9.27 (up from $8.15; 2026 EPS forecast revised to $7.95 from $7.46), above ITT's long-term historical average given portfolio optimization toward high-growth markets. The integration of SPX FLOW, which closed in March, accounted for a significant portion of the top-line expansion (up 33% Y/Y) and was immediately accretive to adjusted earnings per share - even after accounting for initial acquisition-related costs and financing. We are encouraged by ITT's early results in integrating SPX FLOW, with $15M of cost synergies expected by year-end. Underlying organic performance was driven by sustained strength in aerospace and defense within the CCT segment, share gains in Motion Tech that outpaced a declining automotive market, and robust project and short-cycle activity in the legacy Flow Tech business.

$ITT

Research54d ago

Research Alert: CFRA Lowers Opinion On Ads Of Toyota Motor Corporation To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price to USD150 from USD260, implying a FY 27 (Mar.) P/B of 0.72x, as the latest financial reports and guidance confirm that the structural profit erosion is deeper and more prolonged than we previously anticipated. Our revised FY 27 EPS estimate of JPY2,830, reduced from JPY3,330, reflects the incremental headwind from the Middle East that management has acknowledged it cannot fully absorb on top of the persistent U.S. tariff burden. We initiate a FY 28 EPS forecast of JPY3,210, assuming some degree of stabilization in tariff and geopolitical conditions and a gradual benefit from cost-reduction and value-chain initiatives, but still well short of the levels that would support the previous valuation premium. Our de-rating reflects not only the immediate compression in earnings but also the heightened unpredictability of trade policy and the risk that Toyota's break-even volume remains structurally elevated. We downgrade our rating to Sell from Hold.

$TM

Research54d ago

Research Alert: CFRA Keeps Buy Opinion On Shares Of Willis Towers Watson

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $80 to $300, valuing WTW at 13.5x our '27 adjusted EPS estimate of $22.20 (lowered by $0.20), and at 15.4x our '26 EPS estimate of $19.52 (trimmed by $0.18), versus its one-year avg. forward multiple of 17x and disparate peer group average of 15x. WTW posted Q1 2026 EPS of $3.72 vs. $3.13 in the prior year, beating the $3.65 consensus but missing our $3.85 estimate, though the results reflected continued turnaround progress. Revenue rose 8% to $2.4B, with 3% organic growth demonstrating solid business momentum despite macroeconomic headwinds, while adjusted operating margin expanded 70 bps to 22.3%, reflecting transformation program benefits and disciplined expense management. We are encouraged by the results and WTW's operational discipline, though more competitive conditions may crimp organic revenue growth. We see the current AI-driven fears as overdone. Currently trading at 13x our '26 EPS estimate, a discount to peer and historical averages, we view WTW as undervalued.

$WTW

Showing 3101-3120 of 6464